Bencyclane

This classification denotes a calcium channel blocker with the molecular formula C19H31NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6I97Z6S135, chemically known as 3-((1-benzylcycloheptyl)oxy)-n,n-dimethylpropylamin but generally known as bencyclane, which bears US NIH Compound Identifier 2312. Bencyclane most often comes in base and fumarate forms. European Medicines Agency schedules Bencyclane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05705MIG. The term BENCYCLANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules bencyclane in its Anatomical Therapeutic Chemical (ATC) Classification. BENCYCLANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bencyclane under HS 29221980 and SITC 51461. As of Q4 2014, BENCYCLANE remains the US FDA Preferred Term for this commodity. Bencyclane bears US NLM identifiers UMLS ID C0004969 and NCI Concept Code C74226. SMILES: O(C1(CCCCCC1)Cc1ccccc1)CCCN(C)C.